Transplant Diagnostics Market : Global Demand, VSaaS Market Size, Share and and Future Growth Analysis Report 2026

“Credence Research”
This has consequently resulted in increased growth of transplant diagnostics market. Growing number of organ donations has further led to additional growth of the global transplant diagnostics market.

The latest market report published by Credence Research, Inc. “Transplant Diagnostics Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global transplant diagnostics market was estimated at US$ 609.1 Mn in 2017 expanding at a CAGR of 7.4% from 2018 to 2026, to reach US$ 1,167.4 by 2026.

Market Insights

Antibody-mediated organ allograft rejection is a difficult to treat complication arising from allo-transplantation. Evolution in diagnostic methods has allowed better detection and determination of antibodies specific to organ acceptance and rejection. Furthermore studies are being undertaken to scrutinize the frequency of non-HLA specific antibodies in graft recipients after transplantation and also during transplantation. Evolution in the nature of diagnostic tests improved clinical outcomes of organ transplantation. The risk of organ rejection can be significantly reduced by precise donor matching and donor compatibility. Conventional techniques such as human leukocyte antigen (HLA) typing are used worldwide. However, the use of molecular assay methods such as PCR and sequencing has been proven to be efficient and are gaining demand in the global markets.

Browse the full report at

Get Sample with more graphs and details for better understanding:

Growing numbers of transplantation procedures is anticipated to increase the demand for transplant diagnostics. International health organizations such as the WHO have devised healthcare plans and agendas to increase awareness with respect to uptake of organ and stem cell transplantation. For instance organ harvesting initiative undertaken by the European Commission has resulted in increased availability of organs for transplantation in the region and also increased general awareness.

The global transplant diagnostics market is broadly classified on the basis of technologies, applications, transplant type, products, usage areas, and geographical demarcation. Non-molecular assays currently dominate the global transplant diagnostics market. Swift progress in the field of end stage organ failures and transplant medicine and increasing adoption of immunomodulatory treatments has increased the demand for transplant diagnostic methods in the global markets.

Among the product types reagents and consumables segment dominated the global market in 2017 and will continue its lead through the forecast period. Repeat purchase volume is the key factor supporting the dominance of this segment. Hospitals and diagnostic laboratories are being observed to enter into long term contracts with suppliers to avail security from price variations and ensure persistent supply of frequently needed products. Based on applications, pre- and post-transplantation diagnostics occupy the leading share globally.

Solid organ transplantation is the key area where transplantation diagnostics methods are highly used. Sheer volume of transplantation procedures of heart, lungs, liver, pancreas, and kidneys is the driving factor to the dominance of this segment. On the other hand, enhancing developments in the area of stem cell transplantation and its growing application in several disease areas will render swift market growth to this segment. Among the usage areas, hospitals and transplant centers due to greater patient footfall and high volume of post-transplant follow-ups will occupy the largest market share during the forecast period.

North America is the clear leader in the global transplant diagnostics market. Favorable regulatory scenario, greater awareness, and significantly large patient pool with chronic diseases at high risk of organ failure are the key factors characterizing the North America market. Asia Pacific will witness fast market growth and will cannibalize on the market share of North America during 2018 to 2026. Improving awareness, increasing incomes of the population, developing skill sets of healthcare practitioners and government support are the primary drivers supporting the growth of Asia Pacific market. The global transplant diagnostics market is highly competitive with a limited number of players engaged in the business. Product differentiation in this industry is limited yet distinguished, thus enhancing the overall competition among the market players.

Key Market Movements:

  • Significant growth in global geriatric population, along with growing risk of organ failure
  • High incidence of organ failure in developed markets of North America and Europe
  • Increasing awareness supported by health organizations and governments promoting the uptake of transplantation procedures
  • Limited organ donors challenging the market growth


Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Transplant Diagnostics Market Portraiture
2.2. Global Transplant Diagnostics Market, by Technology, 2017 (US$ Mn)
2.3. Global Transplant Diagnostics Market, by Transplant Type, 2017 (US$ Mn)
2.4. Global Transplant Diagnostics Market, by Application, 2017 (US$ Mn)
2.5. Global Transplant Diagnostics Market, by Product, 2017 (US$ Mn)
2.6. Global Transplant Diagnostics Market, by Usage Area, 2017 (US$ Mn)
2.7. Global Transplant Diagnostics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Transplant Diagnostics Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Transplant Diagnostics Market, by Key Players, 2017

Chapter 4. Global Transplant Diagnostics Market, by Technology, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Molecular Assays
4.2.1. PCR Based Molecular Assays
4.2.2. Sequencing Based Molecular Assays Sanger sequencing Next generation sequencing 
4.3. Non-molecular Assays
4.3.1. Serological Assays
4.3.2. Mixed Lymphocyte Culture (MLC) Testing

………………………..toc continued

Browse the full report at

Get Sample with more graphs and details for better understanding:

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa. 

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.


Media Contact
Company Name: Credence Research, Inc
Contact Person: Chris Smith, Global Sales Manager
Email: Send Email
Phone: +1-800-361-8290
Address:105 N 1st ST #429, SAN JOSE, CA 95103 US
State: California
Country: United States